![Hildegund C. J. Ertl](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Hildegund C. J. Ertl
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Virion Therapeutics LLC
![]() Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE.
9
| Holding Company | Biotechnology | 9 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Hildegund C. J. Ertl
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Meridian Venture Partners LLC
![]() Meridian Venture Partners LLC Investment ManagersFinance Meridian Venture Partners LLC (MVP Capital Partners) is a private equity firm founded in 1985 by Robert E. Brown and Bob Brown. The firm is headquartered in Radnor, Pennsylvania. | Investment Managers | Private Equity Investor | |
INTERMUNE INC | Biotechnology | Corporate Officer/Principal | |
CHIMERIX, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
AudioAudit, Inc.
![]() AudioAudit, Inc. Internet Software/ServicesTechnology Services AudioAudit, Inc. provides broadcast performance management and tracking solutions. It provides a web-based platform that automates the tracking process of advertising campaigns suitable for ad agencies, media buyers, and broadcasters. The company was founded by Burton L. Greenberg and Paul Hummel in 1994 and is headquartered in Paramus, NJ. | Internet Software/Services | Director of Finance/CFO | |
Asklepios BioPharmaceutical, Inc.
![]() Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Biotechnology | Director/Board Member | |
INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Midway Pharmaceuticals, Inc.
![]() Midway Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Midway Pharmaceuticals, Inc. develops non-antibiotic therapies. It capitalizes on the finding the molecular weight polymers, taken orally but not systemically absorbed, can inhibit the pathogenic behavior of bacteria in the GI tract, enhance gut barrier function and promote gastrointestinal healing. The company was founded by John Alverdy, Eugene Chang and Elaine Petrof in 2005 and is headquartered in Spring House, PA. | Pharmaceuticals: Major | Chief Executive Officer | |
Axxia Pharmaceuticals LLC
![]() Axxia Pharmaceuticals LLC Medical DistributorsDistribution Services Axxia Pharmaceuticals LLC commercializes implantable, polymer-based drug delivery technology. It allows surgeons to remove and replace the implant at the end of its therapeutic life. The company is headquartered in Bel Air, MD. | Medical Distributors | Director of Finance/CFO | |
Genomic Expression, Inc.
![]() Genomic Expression, Inc. Pharmaceuticals: MajorHealth Technology Genomic Expression, Inc. is an American company that specializes in RNA analysis to detect diseases, monitor health, and design next-generation cures. The company offers COVID19 PCR testing as well as cancer testing. The company was founded by Gitte L. Pedersen and Morten Lorentz Pedersen, with Gitte L. Pedersen serving as the CEO since incorporation. | Pharmaceuticals: Major | Director of Finance/CFO | |
Keiretsu Capital LLC
![]() Keiretsu Capital LLC Investment ManagersFinance Keiretsu Capital LLC (Keiretsu) is a Venture Capital firm, a subsidiary of Keiretsu Forum LLC founded in 2013 by Matthew le Merle and Randy Williams. The firm headquartered in Seattle, Washington. | Investment Managers | Investment Committee Member | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
University of Pennsylvania | College/University | Graduate Degree | |
Emory University | College/University | Graduate Degree | |
The Johns Hopkins University | College/University | Undergraduate Degree | |
Georgia Health Sciences University | College/University | Doctorate Degree | |
Northwood University (Michigan) | College/University | Masters Business Admin | |
The Pennsylvania State University | College/University | Undergraduate Degree | |
University of Saskatchewan | College/University | Undergraduate Degree | |
University of Wisconsin | College/University | Doctorate Degree | |
University of Phoenix | College/University | Graduate Degree | |
The University of California, San Francisco | College/University | Corporate Officer/Principal | |
University of San Francisco | College/University | Doctorate Degree | |
The North Carolina Biotechnology Center
![]() The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Internet Software/Services | Director/Board Member | |
Mid-Atlantic Diamond Ventures
![]() Mid-Atlantic Diamond Ventures Investment ManagersFinance Mid-Atlantic Diamond Ventures operates as an alternative investment manager. The company was founded in 2003 and is headquartered in Philadelphia, PA. | Investment Managers | Founder | |
Noveome Biotherapeutics, Inc.
![]() Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | Biotechnology | Director/Board Member | |
Immunomic Therapeutics, Inc.
![]() Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | Biotechnology | Founder | |
KSR Associates LLC | Founder | ||
CapGenic Advisors, Inc. | Founder | ||
Perelman School of Medicine | College/University | Corporate Officer/Principal | |
SPARK THERAPEUTICS, INC. | Biotechnology | Founder | |
CRISPR THERAPEUTICS AG | Biotechnology | Director/Board Member | |
UNC School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
The Children's Hospital of Philadelphia
![]() The Children's Hospital of Philadelphia Hospital/Nursing ManagementHealth Services The Children's Hospital of Philadelphia provides health care services. It specializes in pediatrics, research, fetal surgery, pediatric oncology, pediatric cardiology and cardiothoracic surgery, thoracic insufficiency syndrome, and pediatric airway disorders and transplants. The company was founded by Francis West Lewis in 1855 and is headquartered in Philadelphia, PA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Atrin Pharmaceuticals LLC
![]() Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Syantra, Inc.
![]() Syantra, Inc. Miscellaneous Commercial ServicesCommercial Services Syantra, Inc. engages in the development of cancer detection and treatment technology. It offers Syantra DX - Breast Cancer, a blood-based cancer detection assay that utilizes a novel suite of biomarkers and proprietary artificial intelligence-generated algorithms to provide a positive or negative result. The company was founded by Kristina Rinker and Kenneth Fuh and is headquartered in Calgary, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Atrin Pharmaceuticals, Inc.
![]() Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2012, Atrin Pharmaceuticals, Inc. is a DNA Damage Response development company that focuses on a pipeline of products resulting from a series of novel conformationally restricted macrocyclic molecules. Part of Aprea Therapeutics, Inc., the company is based in Doylestown, PA. Atrin Pharmaceuticals was acquired by Aprea Therapeutics, Inc. on May 16, 2022 for $1.33 million. The company's products have the highest known potency for inhibiting ATR and exhibit ATR selectivity with potential broad therapeutic profile. | Pharmaceuticals: Major | Director/Board Member | |
SIRPant Immunotherapeutics, Inc.
![]() SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology SIRPant Immunotherapeutics, Inc. is a clinical-stage immuno-oncology company based in Hummelstown, PA. The company specializes in developing next-generation macrophage-based immunotherapies for the treatment of hematological malignancies and solid tumors. The cell therapy technology employed by SIRPant is based on the reduction of SIRP? expression combined with activation of the patient's own macrophages. This population of SIRP?low activated macrophages is designed to attack the tumor following injection by activating the patient's immune system to produce broad-spectrum anti-tumor activity that utilizes patient T-cells and antibodies targeting cancer neoantigens. The company was founded by Richard F. Fitzgerald, and the CEO is Robert J. Towarnicki. | Biotechnology | Director/Board Member | |
Innovative Genomics Institute | Director/Board Member | ||
American Society of Gene & Cell Therapy
![]() American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Miscellaneous Commercial Services | President | |
Sagemedic Corp.
![]() Sagemedic Corp. Pharmaceuticals: MajorHealth Technology Sagemedic Corp. specializes in precision medicine for cancer patients. The American company's approach is designed to identify the most effective treatment options, overcoming the limitations of genomic testing. Sagemedic was founded by Christian Apfel and Brigitte Apfel, with Christian Apfel serving as CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
Ocean Biomedical, Inc. (United States)
![]() Ocean Biomedical, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Ocean Biomedical, Inc. is a biopharmaceutical company. It engages in the business of discovering and developing therapeutic products in oncology, fibrosis, infectious diseases and inflammation. The company was founded by Chirinjeev Kathuria, Jonathan Kurtis and Jack A. Elias on January 2, 20219 and is headquartered in Providence, RI. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
Vereinigte Staaten | 43 |
Kanada | 3 |
Vereinigtes Königreich | 2 |
Schweiz | 2 |
Sektoral
Health Technology | 19 |
Consumer Services | 15 |
Finance | 4 |
Commercial Services | 4 |
Technology Services | 3 |
Operativ
Director/Board Member | 39 |
Corporate Officer/Principal | 18 |
Founder | 10 |
President | 9 |
Chief Executive Officer | 7 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Thomas Penn | 21 |
Bernard Rudnick | 16 |
Rifat Pamukcu | 12 |
Katherine High | 12 |
M. Berrey | 11 |
Williamson Z. Bradford | 10 |
Sue Currie | 5 |
Andrew Luber | 1 |
Teresa Wright | 1 |
- Börse
- Insiders
- Hildegund C. J. Ertl
- Unternehmensverbindungen